Varney M[au] - Search Results

Year	Number of Results
1983	2
1987	1
1990	6
1991	1
1992	4
1993	3
1994	5
1995	5
1996	8
1997	6
1998	5
1999	13
2000	3
2001	5
2002	11
2003	12
2004	4
2005	9
2006	3
2007	3
2008	6
2009	13
2010	18
2011	16
2012	7
2013	8
2014	8
2015	10
2016	7
2017	12
2018	15
2019	18
2020	7
2021	5
2022	14
2023	6
2024	2

1

Modulating the immune system as a therapeutic target for myelodysplastic syndromes and acute myeloid leukemia.

Putnam C, Kondeti L, Kesler M, Varney M. Putnam C, et al. Among authors: varney m. Biochem Cell Biol. 2023 Dec 1;101(6):481-495. doi: 10.1139/bcb-2022-0374. Epub 2023 Aug 11. Biochem Cell Biol. 2023. PMID: 37566901 Free article. Review.

2

Mike Varney.

Varney M, Mullard A. Varney M, et al. Nat Rev Drug Discov. 2015 Mar;14(3):158-9. doi: 10.1038/nrd4566. Epub 2015 Feb 13. Nat Rev Drug Discov. 2015. PMID: 25677359 No abstract available.

3

Implication of microRNAs in the pathogenesis of MDS.

Fang J, Varney M, Starczynowski DT. Fang J, et al. Among authors: varney m. Curr Pharm Des. 2012;18(22):3170-9. doi: 10.2174/1381612811209023170. Curr Pharm Des. 2012. PMID: 22571695 Free PMC article. Review.

4

Deconstructing innate immune signaling in myelodysplastic syndromes.

Varney ME, Melgar K, Niederkorn M, Smith M, Barreyro L, Starczynowski DT. Varney ME, et al. Exp Hematol. 2015 Aug;43(8):587-598. doi: 10.1016/j.exphem.2015.05.016. Epub 2015 Jul 2. Exp Hematol. 2015. PMID: 26143580 Free PMC article. Review.

5

Inactivation of p53 provides a competitive advantage to del(5q) myelodysplastic syndrome hematopoietic stem cells during inflammation.

Muto T, Walker CS, Agarwal P, Vick E, Sampson A, Choi K, Niederkorn M, Ishikawa C, Hueneman K, Varney M, Starczynowski DT. Muto T, et al. Among authors: varney m. Haematologica. 2023 Oct 1;108(10):2715-2729. doi: 10.3324/haematol.2022.282349. Haematologica. 2023. PMID: 37102608 Free PMC article.

6

The Role of G Protein-Coupled Receptors and Receptor Kinases in Pancreatic β-Cell Function and Diabetes.

Varney MJ, Benovic JL. Varney MJ, et al. Pharmacol Rev. 2024 Feb 13;76(2):267-299. doi: 10.1124/pharmrev.123.001015. Pharmacol Rev. 2024. PMID: 38351071 Free PMC article. Review.

7

Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma.

Sharma B, Singh S, Varney ML, Singh RK. Sharma B, et al. Among authors: varney ml. Expert Opin Ther Targets. 2010 Apr;14(4):435-42. doi: 10.1517/14728221003652471. Expert Opin Ther Targets. 2010. PMID: 20230195 Free PMC article. Review.

8

ω-Hydroxy isoprenoid bisphosphonates as linkable GGDPS inhibitors.

Bhuiyan NH, Varney ML, Bhattacharya DS, Payne WM, Mohs AM, Holstein SA, Wiemer DF. Bhuiyan NH, et al. Among authors: varney ml. Bioorg Med Chem Lett. 2019 Oct 1;29(19):126633. doi: 10.1016/j.bmcl.2019.126633. Epub 2019 Aug 20. Bioorg Med Chem Lett. 2019. PMID: 31474482 Free PMC article.

9

Self-mixing in microtubule-kinesin active fluid from nonuniform to uniform distribution of activity.

Bate TE, Varney ME, Taylor EH, Dickie JH, Chueh CC, Norton MM, Wu KT. Bate TE, et al. Among authors: varney me. Nat Commun. 2022 Nov 2;13(1):6573. doi: 10.1038/s41467-022-34396-1. Nat Commun. 2022. PMID: 36323696 Free PMC article.

10

Investigation of the activity of a novel tropolone in osteosarcoma.

Haney SL, Feng D, Kollala SS, Chhonker YS, Varney ML, Williams JT, Ford JB, Murry DJ, Holstein SA. Haney SL, et al. Among authors: varney ml. Drug Dev Res. 2024 Feb;85(1):e22129. doi: 10.1002/ddr.22129. Epub 2023 Nov 14. Drug Dev Res. 2024. PMID: 37961833

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

256 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

256 results

Results by year